Park Avenue Securities’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Sell
51,742
-14,892
-22% -$489K 0.01% 806
2026
Q1
$2.48M Buy
66,634
+16,893
+34% +$696K 0.02% 491
2025
Q4
$2.33M Buy
49,741
+848
+2% +$36.7K 0.02% 499
2025
Q3
$2.05M Buy
48,893
+28,307
+138% +$1.24M 0.02% 577
2025
Q2
$906K Sell
20,586
-14,256
-41% -$646K 0.01% 814
2025
Q1
$1.75M Buy
+34,842
New +$1.73M 0.02% 432
2023
Q1
Sell
-9,367
Closed -$434K 877
2022
Q4
$434K Sell
9,367
-339
-3% -$15.4K 0.01% 832
2022
Q3
$425K Buy
+9,706
New +$446K 0.01% 771
2022
Q1
Sell
-4,231
Closed -$225K 1144
2021
Q4
$225K Buy
+4,231
New +$213K ﹤0.01% 1016

Other funds holding G

Park Avenue Securities's G Position: Q2 2026 in Review

Park Avenue Securities reduced its Genpact (G) stake by 22% in Q2 2026, selling an estimated $489K and leaving 51,742 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #806.

Park Avenue Securities first reported a position in G in Q4 2021 and has held it in 9 quarters since. The position peaked at $2.48M in Q1 2026. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Park Avenue Securities held 51,742 shares of Genpact worth $1.42M as of Q2 2026.
  • Park Avenue Securities sold 14,892 Genpact shares in Q2 2026, an estimated $489K.
  • Genpact made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #806 holding.
  • Park Avenue Securities first reported a position in Genpact in Q4 2021 and has held it in 9 quarters since.
  • Park Avenue Securities's Genpact position peaked at $2.48M in Q1 2026.
  • 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.